Literature DB >> 2115867

Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase.

K Tsukamoto1, R Ohno, T Sawai.   

Abstract

The cephalosporinase of Citrobacter freundii GN346 is a class C beta-lactamase, consisting of 361 amino acids and exhibiting the substrate profile of a typical cephalosporinase. On the conversion of a conserved glutamic acid at residue 219 to lysine, the substrate spectrum of the cephalosporinase was extended to oxyimino cephalosporins, aztreonam and carbenicillin, which are essentially undesirable substrates for the enzyme. Escherichia coli cells carrying the mutant gene showed higher resistance levels to cefuroxime, aztreonam, and carbenicillin, but a lower resistance level to cefoxitin, than cells carrying the wild gene. The kcat values of the purified mutant enzyme for ceftazidime, cefuroxime, and cefmenoxime were 77,100, and 300 times those of the wild enzyme, respectively. The relative Vmax values of the mutant enzyme for aztreonam and carbenicillin were determined to be 11 and 23 times those of the wild enzyme, respectively, but the value of the mutant enzyme for cefoxitin was only one-third that of the wild enzyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115867      PMCID: PMC213260          DOI: 10.1128/jb.172.8.4348-4351.1990

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  22 in total

1.  Micro-iodometric assay for penicillinase.

Authors:  R P NOVICK
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

Review 2.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

3.  The structure of beta-lactamases.

Authors:  R P Ambler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1980-05-16       Impact factor: 6.237

4.  Cefuroxime - a new cephalosporin antibiotic.

Authors:  C H O'Callaghan; R B Sykes; D M Ryan; R D Foord; P W Muggleton
Journal:  J Antibiot (Tokyo)       Date:  1976-01       Impact factor: 2.649

5.  A set of bacterial strains for evaluation of beta-lactamase-stability of beta-lactam antibiotics.

Authors:  T Sawai; T Yoshida; K Tsukamoto; S Yamagishi
Journal:  J Antibiot (Tokyo)       Date:  1981-10       Impact factor: 2.649

6.  Characterization of eight beta-lactamases of Gram-negative bacteria.

Authors:  T Sawai; M Kanno; K Tsukamoto
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

7.  Amino acid sequence, active-site residue, and effect of suicide inhibitors on cephalosporinase of Citrobacter freundii GN346.

Authors:  T Sawai; A Yamaguchi; K Tsukamoto
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

8.  Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.

Authors:  M H Richmond; S Wotton
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Role of lysine-67 in the active site of class C beta-lactamase from Citrobacter freundii GN346.

Authors:  K Tsukamoto; K Tachibana; N Yamazaki; Y Ishii; K Ujiie; N Nishida; T Sawai
Journal:  Eur J Biochem       Date:  1990-02-22
View more
  9 in total

1.  Identification of residues critical for catalysis in a class C beta-lactamase by combinatorial scanning mutagenesis.

Authors:  Shalom D Goldberg; William Iannuccilli; Tuan Nguyen; Jingyue Ju; Virginia W Cornish
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

2.  Sequences of homologous beta-lactamases from clinical isolates of Serratia marcescens with different substrate specificities.

Authors:  N Matsumura; S Minami; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

Review 3.  Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations: The "Price of Progress".

Authors:  Krisztina M Papp-Wallace; Andrew R Mack; Magdalena A Taracila; Robert A Bonomo
Journal:  Infect Dis Clin North Am       Date:  2020-09-30       Impact factor: 5.982

Review 4.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

5.  Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome.

Authors:  A Raimondi; F Sisto; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

6.  Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei.

Authors:  D Girlich; T Naas; S Bellais; L Poirel; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

7.  Heterogeneity of AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes.

Authors:  D Girlich; T Naas; S Bellais; L Poirel; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 8.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

9.  Interaction of oxyimino beta-lactams with a class C beta-lactamase and a mutant with a spectrum extended to beta-lactams.

Authors:  M Nukaga; K Tsukamoto; H Yamaguchi; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.